RS

Rajeev Shah

Portfolio Manager & Managing Director

Boston, Massachusetts

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Rajeev

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Eidos Therapeutics

Series B

Total Funding: $64M

Dyne Therapeutics

Seed

Total Funding: $170M

KalVista Pharmaceuticals

Series B

Total Funding: $33M

Aeglea BioTherapeutics

Series B

Total Funding: $44M

Work Experience

RC
RA Capital Management, LLC

2004

  • Managing Director & Portfolio Manager

    2004

    RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital® to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.

Altus Pharmaceuticals

2000 - 2004

  • Project Manager

    2000 - 2004